Webinars

Join Dr. Juzar Ali as he provides an update on identification, screening, and management of TB and non-tuberculosis mycobacteria (NTM) in non-HIV immune compromised patients seen specially in Rheumatology practices. Dr. Ali also discusses practical issues faced by physicians taking care of patients being treated with immune suppressive medications and biologic agents. (run time: presentation … Read more

Join Dr. Ruth Brignall as she reviews the immunology of SARS-CoV-2 infection and discusses how a cell-mediated immunity test could help to develop our understanding of immune responses to SARS-CoV-2 and provide additional insights into potential protective immunity against reinfection. (run time: presentation 37m35s, Q&A session 7m45s)

Join Ana M. Alvarez, MD as she presents an update on the diagnosis of latent Mycobacterium tuberculosis (TB) infection in children. Dr. Alvarez will review illustrative cases from pediatric patients, and she will discuss FAQs about TB infection in children. At the conclusion of this program, participants should be able to: Define latent TB infection (LTBI) List the tests currently … Read more

The Tuberculin Skin Test was developed in 1907. While it was highly effective in the US for most of the 20th century, it no longer meets the needs of the 21st century. At the end of the presentation and discussion participants will be able to: Describe the diagnostic immunological testing options available for TB screening … Read more

Join Dr. Roy Chemaly as he discusses effective TB testing methods in the immunocompromised population. At the end of the presentation and discussion participants will be able to: Review current tuberculosis (TB) statistics Differentiate between the 3 TB testing methods Identify what constitutes immunocompromised patient populations Identify the clinical utility of interferon-gamma release assays (IGRAs) … Read more

In recent years, the risk for tuberculosis exposure in healthcare settings has declined while both testing and treatment options have improved. This changing dynamic led to the development of updated guidelines: Tuberculosis Screening, Testing, and Treatment of U.S. Healthcare Personnel: Recommendations from the National Tuberculosis ControllersAssociation and CDC, 2019. Join us for a free webinar … Read more

As part of the End TB Strategy, healthcare providers in tuberculosis control have united with a goal of ending the global TB epidemic by 2035. Join Dr. Elizabeth Talbot as she discusses the importance of efficient TB and LTBI diagnosis, reviews new TB/LTBI diagnosis guidance and available testing methods, and shares diagnosis case experiences. (run … Read more